Search Results

There are 22447 results for: content related to: Caffeine consumption and risk of dyskinesia in CALM - PD

  1. Which dyskinesia scale best detects treatment response?

    Movement Disorders

    Volume 28, Issue 3, March 2013, Pages: 341–346, Christopher G. Goetz, Glenn T. Stebbins, Kathryn A. Chung, Robert A. Hauser, Janis M. Miyasaki, Anthony P. Nicholas, Werner Poewe, Klaus Seppi, Olivier Rascol, Mark A. Stacy, John G. Nutt, Caroline M. Tanner, Alison Urkowitz, Jean A. Jaglin and Song Ge

    Version of Record online : 6 FEB 2013, DOI: 10.1002/mds.25321

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  3. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  4. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  5. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  6. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1064–1071, C. Warren Olanow, Karl Kieburtz, Olivier Rascol, Werner Poewe, Anthony H. Schapira, Murat Emre, Helena Nissinen, Mika Leinonen, Fabrizio Stocchi and for the Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators

    Version of Record online : 29 APR 2013, DOI: 10.1002/mds.25364

  7. Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations

    Movement Disorders

    Volume 25, Issue 9, 15 July 2010, Pages: 1131–1142, Carlo Colosimo, Pablo Martínez-Martín, Giovanni Fabbrini, Robert A. Hauser, Marcelo Merello, Janis Miyasaki, Werner Poewe, Cristina Sampaio, Olivier Rascol, Glenn T. Stebbins, Anette Schrag and Christopher G. Goetz

    Version of Record online : 22 MAR 2010, DOI: 10.1002/mds.23072

  8. A cup of coffee a day keeps dyskinesia away?

    Movement Disorders

    Volume 28, Issue 3, March 2013, Pages: 265–267, Peter Jenner

    Version of Record online : 27 FEB 2013, DOI: 10.1002/mds.25409

  9. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  10. Dyskinesia Induced by Levodopa and Dopamine Agonists in Patients with Parkinson's Disease

    Drug Induced Movement Disorders, Second Edition

    John G. Nutt, Matthew A. Brodsky, Pages: 313–350, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753217.ch13

  11. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  12. A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease

    Movement Disorders

    Volume 31, Issue 9, September 2016, Pages: 1373–1380, François Tison, Charlotte Keywood, Mark Wakefield, Franck Durif, Jean-Christophe Corvol, Karla Eggert, Mark Lew, Stuart Isaacson, Erwan Bezard, Sonia-Maria Poli, Christopher G. Goetz, Claudia Trenkwalder and Olivier Rascol

    Version of Record online : 23 MAY 2016, DOI: 10.1002/mds.26659

  13. Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease

    Movement Disorders

    Volume 31, Issue 4, April 2016, Pages: 501–511, Annalisa Pinna, Wai Kin D. Ko, Giulia Costa, Elisabetta Tronci, Camino Fidalgo, Nicola Simola, Qin Li, Mojgan Aghazadeh Tabrizi, Erwan Bezard, Manolo Carta and Micaela Morelli

    Version of Record online : 12 FEB 2016, DOI: 10.1002/mds.26475

  14. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1088–1096, Erwan Bezard, Elisabetta Tronci, Elsa Y. Pioli, Qin Li, Gregory Porras, Anders Björklund and Manolo Carta

    Version of Record online : 6 FEB 2013, DOI: 10.1002/mds.25366

  15. The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate?

    Human Brain Mapping

    Volume 30, Issue 10, October 2009, Pages: 3102–3114, Merideth A. Addicott, Lucie L. Yang, Ann M. Peiffer, Luke R. Burnett, Jonathan H. Burdette, Michael Y. Chen, Satoru Hayasaka, Robert A. Kraft, Joseph A. Maldjian and Paul J. Laurienti

    Version of Record online : 13 FEB 2009, DOI: 10.1002/hbm.20732

  16. Dyskinesias in Parkinsonian Syndromes

    Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment

    S. Elizabeth Zauber, Christopher G. Goetz, Pages: 297–310, 2012

    Published Online : 24 FEB 2012, DOI: 10.1002/9781444346183.ch19

  17. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  18. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias

    Movement Disorders

    Volume 30, Issue 6, May 2015, Pages: 796–804, Perdita Cheshire, Scott Ayton, Kelly L. Bertram, Helen Ling, Abi Li, Catriona McLean, Glenda M. Halliday, Sean S. O'Sullivan, Tamas Revesz, David I. Finkelstein, Elsdon Storey and David R. Williams

    Version of Record online : 4 FEB 2015, DOI: 10.1002/mds.26144

  19. Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease

    Movement Disorders

    Volume 30, Issue 10, September 2015, Pages: 1361–1370, Carolin Curtze, John G. Nutt, Patricia Carlson-Kuhta, Martina Mancini and Fay B. Horak

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26269

  20. The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile

    Movement Disorders

    Volume 23, Issue 16, 15 December 2008, Pages: 2398–2403, Christopher G. Goetz, John G. Nutt and Glenn T. Stebbins

    Version of Record online : 21 NOV 2008, DOI: 10.1002/mds.22341